Genmab A/S reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was DKK 5,402 million compared to DKK 4,169 million a year ago. Net income was DKK 1,408 million compared to DKK 1,335 million a year ago. Basic earnings per share from continuing operations was DKK 21.85 compared to DKK 20.46 a year ago. Diluted earnings per share from continuing operations was DKK 21.7 compared to DKK 20.28 a year ago.
For the six months, sales was DKK 9,545 million compared to DKK 7,003 million a year ago. Net income was DKK 2,733 million compared to DKK 1,545 million a year ago. Basic earnings per share from continuing operations was DKK 42.13 compared to DKK 23.66 a year ago. Diluted earnings per share from continuing operations was DKK 41.85 compared to DKK 23.45 a year ago.